CLAY B SIEGALL Insider Trading for September 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CLAY B SIEGALL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of CLAY B SIEGALL for September 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 12 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 31,269 | 321,758 | 115,443 | |
Sep 12 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Gift | G | 0.00 | 6,148 | 0 | 0 | 6.1 K to 0 (-100.00 %) |
Sep 12 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 50.08 | 31,269 | 1,565,977 | 638,835 | 670.1 K to 638.8 K (-4.67 %) |
Sep 12 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 31,269 | 321,758 | 648,307 | 617 K to 648.3 K (+5.07 %) |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 4,042 | 41,228 | 31,533 | |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 4.45 | 5,411 | 24,079 | 0 | |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 4.45 | 2,200 | 9,790 | 5,411 | |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 1,973 | 20,302 | 0 | |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 10,331 | 105,376 | 0 | |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 45.91 | 5,411 | 248,432 | 617,038 | 622.4 K to 617 K (-0.87 %) |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 4.45 | 5,411 | 24,079 | 622,449 | 617 K to 622.4 K (+0.88 %) |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 45.15 | 2,200 | 99,335 | 617,038 | 619.2 K to 617 K (-0.36 %) |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 4.45 | 2,200 | 9,790 | 619,238 | 617 K to 619.2 K (+0.36 %) |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 44.84 | 4,042 | 181,240 | 617,038 | 621.1 K to 617 K (-0.65 %) |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 4,042 | 41,228 | 621,080 | 617 K to 621.1 K (+0.66 %) |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 1,973 | 20,302 | 617,038 | 615.1 K to 617 K (+0.32 %) |
Sep 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 10,331 | 105,376 | 615,065 | 604.7 K to 615.1 K (+1.71 %) |
Sep 06 2016 | MIRN | Mirna Therapeutics ... | SIEGALL CLAY B | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 |